-
effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
October 01, 2007 - Key Words: vaccine safety, active surveillance, sequential
analysis, meningococcal vaccine, drug safety … occurred
since the beginning of the study period in the following strata:
calendar week of observation, patient … It could be useful not only in vaccine safety studies,
but also during drug safety monitoring, when analysts … We are currently assessing the use of maxSPRT in drug
safety monitoring.18 Drug safety studies entail … Vaccine safety monitoring.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0376-140408.pdf
November 06, 2013 - Key Questions
from Nominator:
Patient … factors prompting
the admission
Individual and family felt the stay was sufficient to address safety … hospitalizations for persons with SMI
and the circumstances surrounding hospitalization that promote positive patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - In a clinical trial, the effectiveness and safety of BT versus a sham procedure in patients (n = 288) … Thermoplasty System for treatment-resistant asthma
studies to investigate the system’s long-term safety … Effectiveness and safety of bronchial
thermoplasty in the treatment of severe asthma: a
multicenter … PMA P080032: FDA summary of
safety and effectiveness data (SSED) for the
Alair bronchial thermoplasty … Safety
of bronchial thermoplasty out to 5 years in
patients with severe refractory asthma: research
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-amendement-may-2025.pdf
January 01, 2025 - regulation and management, behavioral planning, family engagement
and communication training, and practical safety … intervals), directness of the evidence to the
KQs (focusing on whether the outcomes were important to patients … Intervention research with persons at high risk for
suicidality: safety and ethical considerations. … The SAFETY program: a treatment-development
trial of a cognitive-behavioral family treatment for adolescent … Key Informants
Key Informants are the end-users of research; they can include patients and caregivers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
June 01, 2010 - It is unfair to label all companies as profit-driven over safety-
driven. … Same page, line 56: Patient
should be plural. … basis, these direct-to patient
distribution channels are only used for patients with hemophilia or … Further, this trial was designed primarily as a safety and proof-of-
concept trial. … For example, there are reasons to believe that certain
patient populations (e.g., older patients and
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Although propofol may be preferred for these
reasons, safety concerns complicate its use. … The intent is to improve
seniors’ safety, clinical outcomes, and quality of care and to reduce admissions … the Sedasys can be used.7
The FDA approval requires that EES conduct two postmarketing studies on safety … Clinicians can access
objective, accurate, and timely data about patient adherence, to monitor patients … It may be
12
solely age-based (i.e., patients 65 years and older) or also based on patient complaint
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
October 12, 2015 - KQ 1: What are the comparative safety and effectiveness of available treatment strategies for
women … KQ 2: What are the comparative safety and effectiveness of available treatment strategies for
women … KQ 3: What are the comparative safety and effectiveness of available treatment strategies for
women … KQ 4: What are the comparative safety and effectiveness of available treatments for women with
tubal … Safety of assisted reproductive technology
in the United States, 2000-2011.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2021.pdf
January 01, 2021 - Safety of vaccines used for routine immunization in the
United States: An updated systematic review … Increasing out-of-pocket costs for neurologic care for privately
insured patients. … National Highway Traffic Safety Administration (NHTSA)
5. … Agency for Healthcare Research and Quality (AHRQ) - Center for Quality Improvement and Patient
Safety … Patient-Centered Outcomes Research Institute (PCORI)
14.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - How do the efficacy, effectiveness,
safety, and adverse effects of treatment with DMARDs
differ among … How do the efficacy, effectiveness, Insufficient Only one study—an RCT of methotrexate versus
safety, … In addition, patient-level
meta-analysis may help address this challenge. … • The need for study populations who are
representative of typical patients with JIA. … Randomized discontinuation trials
have helped to define the risk of flare in patients who
respond to
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - In secondary analyses, we explored a broader patient
population by including those studies that had … Insufficient 13 studies (9 good quality, 4 fair) reported data pertinent to safety concerns or risks … Study results on these
issues were reported for the total patient population and
did not separate the … Third, most studies lacked long-term followup
of the patient population, which affected our ability … Reporting of risk, harms, and/or safety outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
January 01, 2010 - about the outcomes, clinical effectiveness, safety, and
appropriateness of health care items and services … Effectiveness and Safety of Drug-
Eluting Stents in Ontario. … Balancing
Efficacy and Safety of Drug-Eluting
Stents in Patients Undergoing
Percutaneous Coronary … Safety and Efficacy of Sirolimus- and
Paclitaxel-Eluting Coronary Stents. … Unadjusted baseline characteristics of patients in study population
Patient Characteristics Study
-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - Key Words: hierarchically optimal classification tree analysis,
patient safety indicators, surveillance … The Agency for Health-
care Research and Quality (AHRQ) has developed 20 pro-
vider-level patient safety … AHRQ Quality Indica-
tors—Guide to Patient Safety Indicators. … Discriminating geriatric and nongeriatric patients using
functional status information: an example of … Tracking rates of patient safety
indicators over time: lessons from the Veterans Administration.
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
January 01, 2012 - with the underlying disease and its
severity, general health status or frailty, quality of life,
and patient … A comparison between aripiprazole,
an antipsychotic agent with a relatively favorable
metabolic safety … treated with the oral dosage form mainly
due to the different way of administering the drugs
(patient … It is common
that information about the patient, exposure or
comparison treatment, and/or outcome is … does not necessarily remove
confounding by severity.21
For clinical effectiveness or safety questions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
January 01, 2018 - of mental health apps, causes
providers to be hesitant about recommending apps.7 Most providers and patients … researchers, health care providers,
informaticians and technologists, app developers, as well as patient … We plan to have a separate call for patient/caregiver KI at the start of the
project, with questions … /clients and health care providers;
security and privacy features such as data usage and sharing of … how it works, how it is currently
used or might be used, and which features may be important from a patient
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
May 01, 2022 - Patient Education as Topic/
A-8
34. … How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical or … How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical comorbidities … How do harms vary depending on: (1) patient demographics (e.g., age, gender);
(2) patient medical and … safety and pain management: a
systematic review and meta-analysis.
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Using the
system would represent a way to purportedly enhance patient mobility and allow patients to … fumarate because of the efficacy and safety profile reported in patients with RRMS, the
experts thought … Regarding acceptance by both patients and clinicians, one clinical expert commented, “The safety
profile … Experts generally agreed that potential patient adoption would be high because of patients’ desire to … One research expert opined that elderly patients may have more reservations than a younger patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
March 27, 2014 - How do the efficacy, effectiveness, safety, and adverse effects of
treatment with DMARDs differ among … Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis (JIA) indicated there were
new safety … activity:
Active joint count (AJC)
Physician global assessment of disease activity (PGA)
Parent/patient
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_research-protocol.pdf
December 09, 2009 - It may be patient defined or proxy reported. … For the questions on safety and adverse effects, in addition to the above databases, we
will search … Does functional recovery in elderly hip
fracture patients differ between patients admitted from long-term … Pain management after total joint replacement and its impact on
patient outcomes. … Evidence for
safety of
pharmacologic and
nonpharmacologic
pain management
interventions
K3:
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
November 01, 2008 - Observational studies based on patient registries. … Celecoxib Long-term Arthritis Safety Study
[see comment]. … http://www3.niaid.nih.gov/research/resource
s/DAIDSClinRsrch/Safety/. … Rather, adverse events are identified based on patient reports made on their
own initiative. … Safety Substantive evidence of an absence of harm.
-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
November 01, 2008 - Observational studies based on patient registries. … Celecoxib Long-term Arthritis Safety Study
[see comment]. … http://www3.niaid.nih.gov/research/resource
s/DAIDSClinRsrch/Safety/. … Rather, adverse events are identified based on patient reports made on their
own initiative. … Safety Substantive evidence of an absence of harm.